Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 10;63(22):2388-94.
doi: 10.1016/j.jacc.2014.03.025. Epub 2014 Apr 9.

Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?

Vinay Kini  1 , Mohamad Khaled Soufi  2 , Rajat Deo  1 , Andrew E Epstein  3 , Rupa Bala  1 , Michael Riley  1 , Peter W Groeneveld  4 , Alaa Shalaby  2 , Sanjay Dixit  5
Affiliations

Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?

Vinay Kini et al. J Am Coll Cardiol. .

Abstract

Objectives: This study sought to determine how often patients with primary prevention implantable cardioverter-defibrillators (ICDs) meet guideline-derived indications at the time of generator replacement.

Background: Professional societies have developed guideline criteria for the appropriate implantation of an ICD for the primary prevention of sudden cardiac death. It is unknown whether patients continue to meet criteria when their devices need replacement for battery depletion.

Methods: We performed a retrospective chart review of patients undergoing replacement of primary prevention ICDs at 2 tertiary Veterans Affairs Medical Centers. Indications for continued ICD therapy at the time of generator replacement included a left ventricular ejection fraction (LVEF) ≤35% or receipt of appropriate device therapy.

Results: In our cohort of 231 patients, 59 (26%) no longer met guideline-driven indications for an ICD at the time of generator replacement. An additional 79 patients (34%) had not received any appropriate ICD therapies and had not undergone reassessment of their LVEF. Patients with an initial LVEF of 30% to 35% were less likely to meet indications for ICD therapy at the time of replacement (odds ratio: 0.52; 95% confidence interval: 0.30 to 0.88; p = 0.01). Patients without ICD indications subsequently received appropriate ICD therapies at a significantly lower rate than patients with indications (2.8% vs. 10.7% annually, p < 0.001). If ICD generator explantations were performed instead of replacements in the patients without ICD indications, the cost savings would be $1.6 million.

Conclusions: Approximately 25% of patients who receive primary prevention ICDs may no longer meet guideline indications for ICD use at the time of generator replacement, and these patients receive subsequent ICD therapies at a significantly lower rate.

Keywords: ICD generator replacement; implantable cardioverter-defibrillator; sudden cardiac death.

PubMed Disclaimer

Figures

Figure 1
Figure 1. ICD Indications at Elective Generator Replacement
In our cohort of 231 patients, an implantable cardioverter-defibrillator (ICD) was indicated in 93 patients (40%), not indicated in 59 patients (26%), and indications were unclear in 79 patients (34%).
Figure 2
Figure 2. Subsequent ICD Therapies After Elective Generator Replacement
Patients with no ICD indication at the time of generator replacement subsequently receive significantly fewer ICD therapies compared with patients with an ICD indication (2.8% vs. 10.7% per person-year, p < 0.001). ICD = implantable cardioverter-defibrillator.
See this image and copyright information in PMC

Comment in

References

    1. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease (MUSTT) N Engl J Med. 1999;341:1882–90. - PubMed
    1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction (MADIT-II) N Engl J Med. 2002;346:877–83. - PubMed
    1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure (SCD-HeFT) N Engl J Med. 2005;352:225–37. - PubMed
    1. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51:e1–62. - PubMed
    1. Sharpe DN, Murphy J, Coxon R, Hannan SF. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation. 1984;70:271–8. - PubMed